Novabridge Biosciences Stock Probability of Future Stock Price Finishing Over 4.27
| NBP Stock | 4.27 0.29 7.29% |
Closest to current price NovaBridge long PUT Option Payoff at Expiration
NovaBridge | Build AI portfolio with NovaBridge Stock |
NovaBridge Biosciences Target Price Odds to finish over 4.27
The tendency of NovaBridge Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 4.27 | 90 days | 4.27 | about 59.38 |
Based on a normal probability distribution, the odds of NovaBridge Biosciences to move above the current price in 90 days from now is about 59.38 (This NovaBridge Biosciences probability density function shows the probability of NovaBridge Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon the stock has the beta coefficient of 1.18 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, NovaBridge Biosciences will likely underperform. Additionally NovaBridge Biosciences has an alpha of 0.2668, implying that it can generate a 0.27 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). NovaBridge Biosciences Price Density |
| Price |
Predictive Modules for NovaBridge Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NovaBridge Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.NovaBridge Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. NovaBridge Biosciences is not an exception. The market had few large corrections towards the NovaBridge Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold NovaBridge Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of NovaBridge Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.27 | |
β | Beta against Dow Jones | 1.18 | |
σ | Overall volatility | 0.59 | |
Ir | Information ratio | 0.05 |
NovaBridge Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NovaBridge Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NovaBridge Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NovaBridge Biosciences had very high historical volatility over the last 90 days | |
| NovaBridge Biosciences has a very high chance of going through financial distress in the upcoming years | |
| NovaBridge Biosciences was previously known as I Mab and was traded on NASDAQ Exchange under the symbol IMAB. | |
| Reported Net Loss for the year was (49.7 M) with profit before taxes, overhead, and interest of 0. | |
| NovaBridge Biosciences generates negative cash flow from operations | |
| Latest headline from news.google.com: Annexon Upgraded at Chardan Capital - MarketBeat |
NovaBridge Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NovaBridge Stock often depends not only on the future outlook of the current and potential NovaBridge Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NovaBridge Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 81.2 M | |
| Cash And Short Term Investments | 173.4 M |
NovaBridge Biosciences Technical Analysis
NovaBridge Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. NovaBridge Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NovaBridge Biosciences. In general, you should focus on analyzing NovaBridge Stock price patterns and their correlations with different microeconomic environments and drivers.
NovaBridge Biosciences Predictive Forecast Models
NovaBridge Biosciences' time-series forecasting models is one of many NovaBridge Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary NovaBridge Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about NovaBridge Biosciences
Checking the ongoing alerts about NovaBridge Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for NovaBridge Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| NovaBridge Biosciences had very high historical volatility over the last 90 days | |
| NovaBridge Biosciences has a very high chance of going through financial distress in the upcoming years | |
| NovaBridge Biosciences was previously known as I Mab and was traded on NASDAQ Exchange under the symbol IMAB. | |
| Reported Net Loss for the year was (49.7 M) with profit before taxes, overhead, and interest of 0. | |
| NovaBridge Biosciences generates negative cash flow from operations | |
| Latest headline from news.google.com: Annexon Upgraded at Chardan Capital - MarketBeat |
Additional Tools for NovaBridge Stock Analysis
When running NovaBridge Biosciences' price analysis, check to measure NovaBridge Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBridge Biosciences is operating at the current time. Most of NovaBridge Biosciences' value examination focuses on studying past and present price action to predict the probability of NovaBridge Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBridge Biosciences' price. Additionally, you may evaluate how the addition of NovaBridge Biosciences to your portfolios can decrease your overall portfolio volatility.